Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07528300 · ClinicalTrials.gov registry record · NA
Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis
A NA study, sponsored by Tripler Army Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT07528300: Recruiting NA study, sponsored by Tripler Army Medical Center.
NCT07528300 is a NA study that is actively recruiting participants, run by Tripler Army Medical Center. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07528300, a NA study, is actively recruiting participants, sponsored by Tripler Army Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.
Primary Outcome
Reported pain levels on a subjective pain score of 0-10
Interventions
- PROCEDURE Battlefield Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-04-24 |
| Est. Completion | 2028-04-24 |
| Phase | NA |
What NCT07528300 shows while recruiting
NCT07528300 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Battlefield Acupuncture is the first listed.
NCT07528300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07528300 about?
NCT07528300 is a clinical study titled "Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis". Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.
What is the current status of trial NCT07528300?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-04-24. Estimated completion is 2028-04-24.
What interventions are being tested in trial NCT07528300?
The interventions under investigation include: Battlefield Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT07528300?
This trial is sponsored by Tripler Army Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07528300's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI